EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Meropenem resistance in salmonella typhi in a paediatric patient, Lahore, Pakistan

Sami Ahmad, Nadia Siddiq

Journal of the Pakistan Medical Association · 28.05.2026 · 76 (06) · 986-986

DOI: 10.47391/jpma.32362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pakistan Medical Association, online erschienen am 28.05.2026. Verfasst von Sami Ahmad und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Chaudhry Muhammad Akram Teaching and Research Hospital, Lahore, Pakistan. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dear Editor, We report a concerning case of meropenem-resistant Salmonella Typhi in a 5-year-old girl in Lahore, Pakistan, signalling an emerging threat to typhoid treatment. The patient presented with a 10-day history of fever and abdominal pain and wasdiagnosed with extensively drug-resistant (XDR) S. Typhi via blood culture. Initial treatment with meropenem (500 mg thrice daily) failed, with persistent fever and elevated C-reactive protein (268 mg/L). Clinical and Laboratory Standards Institute (CLSI)-compliant disc diffusion revealed meropenem resistance (MIC >32 µg/mL); molecular testing was not available. Combination therapy with colistin (40 mg twice daily) and azithromycin (20 mg/kg/day) resulted in defervescence within 4 days, and she was discharged from hospital after 14 days. Patient data were anonymized, and guardian consent was obtained. Meropenem is a last-resort antibiotic for XDR S. Typhi, which constitutes approximately 25% of typhoid cases in Pakistan (95% CI, 12–44%)[1]. National surveillance indicates meropenem resistance remains rare (around 2%)[1], This case, reported in Lahore, follows a documented case of NDM-5-mediated resistance in Peshawar [2]. The high prevalence of XDR strains in paediatric populations creates significant treatment challenges [3]. The emergence of resistant cases in multiple cities suggests potential plasmid-mediated spread, likely driven by antimicrobial overuse. [1,2]. We urge enhanced antimicrobial stewardship, molecular surveillance for resistance genes, and expanded typhoid conjugate vaccine coverage, which has been shown to be more than 80% effectivein Pakistani children [4]. This case underscores the need for combination therapies and vigilant monitoring to preserve meropenem’s efficacy.

Autor:innen und Institutionen

  • Department of Paediatrics, Chaudhry Muhammad Akram Teaching and Research Hospital, Lahore, Pakistan.

Zitieren

APA

Ahmad, S., & Siddiq, N. (2026). Meropenem resistance in salmonella typhi in a paediatric patient, Lahore, Pakistan. Journal of the Pakistan Medical Association, 76(06), 986-986. https://doi.org/10.47391/jpma.32362

Vancouver

Ahmad S, Siddiq N. Meropenem resistance in salmonella typhi in a paediatric patient, Lahore, Pakistan. Journal of the Pakistan Medical Association. 2026;76(06):986-986. doi:10.47391/jpma.32362

BibTeX
@article{Ahmad2026,
  author = {Ahmad, Sami and Siddiq, Nadia},
  title = {Meropenem resistance in salmonella typhi in a paediatric patient, Lahore, Pakistan},
  journal = {Journal of the Pakistan Medical Association},
  year = {2026},
  volume = {76},
  number = {06},
  pages = {986--986},
  doi = {10.47391/jpma.32362}
}
Kostenlos starten →